Sidra Medicine performs Qatar’s first-ever Osia implant hearing procedure

Doha, Qatar: SidraMedicine, a member of Qatar Foundation, has taken a pioneering step in auditory healthcare by successfully performing Qatar s first...

Doha, Qatar: Sidra Medicine, a member of Qatar Foundation, has taken a pioneering step in auditory healthcare by successfully performing Qatar’s first implantation of the OSIA OSI300 hearing device. 

The implant is a next-generation osseo-integrated hearing device that overcomes many limitations of older bone conduction systems.

Dr. Faisal Abdulkader, Division Chief of Otolaryngology and Audiology at Sidra Medicine, said: "Performing Qatar’s first OSIA implant marks a significant breakthrough in auditory rehabilitation, offering new hope to individuals with not medically treatable conductive hearing loss or single-sided deafness who previously had limited treatment options. This reflects Sidra Medicine’s commitment to cutting-edge medical technology, patient-centered innovation, and world-class expertise in the region.”

An osseo-integrated device is a medical implant that forms a direct connection with bone tissue, enabling sound to be transmitted more efficiently to the inner ear.  It includes a small titanium implant placed using a minimally invasive, flapless technique, along with an external sound processor that converts sound into vibratory signals. 

These signals directly stimulate the inner ear, delivering improved clarity, better speech understanding, and enhanced sound localization, particularly in noisy environments.